title: Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.
authors.affiliation: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France anne-sophie.michallet@chu-lyon.fr.
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Michallet
authors.affiliation: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France.
authors.forename: Yann
authors.initials: Y
authors.lastname: Guillermin
authors.affiliation: Centre Hospitalier Cochin, Department of Hematology, Paris, France.
authors.forename: Benedicte
authors.initials: B
authors.lastname: Deau
authors.affiliation: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France.
authors.forename: Laure
authors.initials: L
authors.lastname: Lebras
authors.affiliation: Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Harel
authors.affiliation: Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
authors.forename: Sandy
authors.initials: S
authors.lastname: Amorin
authors.affiliation: Centre Hospitalier Annecy, Department of Hematology, Pierre Bénite, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Reynes
authors.affiliation: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France Université de Lyon, Faculté de Médecine Lyon-Sud Charles Mérieux, Pierre Bénite, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Salles
authors.affiliation: Hospices Civils de Lyon, Service de Biostatistique, CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, France.
authors.forename: Fabien
authors.initials: F
authors.lastname: Subtil
authors.affiliation: Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
mesh_terms: D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000209:etiology / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000209:etiology / Q000473:pathology; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D008297:Male; D009503:Neutropenia / Q000209:etiology / Q000473:pathology; D011092:Polyethylene Glycols / Q000627:therapeutic use; D012008:Recurrence; D012074:Remission Induction; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D018796:Immunoconjugates; C506643:liposomal doxorubicin; D003841:Deoxycytidine; D011092:Polyethylene Glycols; D014747:Vinblastine; D000079963:Brentuximab Vedotin; D004317:Doxorubicin; D000077235:Vinorelbine; D000093542:Gemcitabine
keywords: Hodgkin lymphoma; SGN 35; combined therapy; refractory
references.citation: Blood. 2001 Feb 1;97(3):616-23
references.pmid: 11157476
references.citation: Lancet. 2002 Jun 15;359(9323):2065-71
references.pmid: 12086759
references.citation: Ann Oncol. 2002 Oct;13(10):1628-35
references.pmid: 12377653
references.citation: J Immunother. 2004 Sep-Oct;27(5):347-53
references.pmid: 15314543
references.citation: J Clin Oncol. 1992 Feb;10(2):210-8
references.pmid: 1732422
references.citation: Cancer Res. 1995 Nov 15;55(22):5335-41
references.pmid: 7585597
references.citation: J Clin Oncol. 1997 Feb;15(2):528-34
references.pmid: 9053474
references.citation: Leukemia. 2005 Sep;19(9):1648-55
references.pmid: 16049514
references.citation: J Clin Oncol. 2008 Jan 10;26(2):204-10
references.pmid: 18182663
references.citation: J Clin Oncol. 2008 Dec 20;26(36):5980-7
references.pmid: 19018090
references.citation: Blood. 2011 Apr 21;117(16):4208-17
references.pmid: 21263152
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2183-9
references.pmid: 22454421
references.citation: Br J Haematol. 2013 Jan;160(2):207-15
references.pmid: 23167437
references.citation: Br J Haematol. 2014 Jul;166(2):306-8
references.pmid: 24673542
references.citation: Lancet Oncol. 2015 Mar;16(3):284-92
references.pmid: 25683846